Viewing Study NCT07035392


Ignite Creation Date: 2025-12-24 @ 3:59 PM
Ignite Modification Date: 2025-12-29 @ 5:22 AM
Study NCT ID: NCT07035392
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-25
First Post: 2025-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
Sponsor: Zhangzhou Municipal Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2024KYZ432
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators